Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
Accelerating Army Innovation with AI, Acquisition Reform
Former Army leader Young Bang discusses harnessing AI, modernizing defense logistics and driving innovation through public-private collaboration.
11m watch -
Modernizing Maritime Medicine on USNS Mercy
Navy's Military Sealift Command is leveraging telepresence technology and extending wireless networks to transform the way medical care is delivered.
8m watch -
Agentic AI Fuels Next Phase of Federal Modernization
Hybrid cloud and agentic AI have the potential to drive efficiency, scalability and mission success across federal government.
3m read -
DOD Prioritizes Data Agility with Risk-Based Shift, SWIFT Program
DOD faces growing pressure to overcome legacy barriers and adopt agile, risk-based strategies exemplified in DOD’s new SWIFT program.
4m read
